COMMODORE CAPITAL LP ELVN Holdings History
COMMODORE CAPITAL LP's Enliven Therapeutics Inc Holding Summary
As of 2025-03-31, COMMODORE CAPITAL LP held 4.67 Mil shares of Enliven Therapeutics Inc(ELVN), totaling $92.00 Mil. This investment constitutes 6.78% of their stock portfolio, and COMMODORE CAPITAL LP now holds 9.53% of the outstanding Enliven Therapeutics Inc(ELVN) stock.
The initial trade took place in 2023Q1. And since then COMMODORE CAPITAL LP has made 7 purchases of ELVN, at an average price of $19.77, for a total of 4.67 Mil shares. Based on historical transaction data and ELVN's current price of $21.95, COMMODORE CAPITAL LP's estimated gain on his ELVN holdings is $10.19 Mil, reflecting a 11.03% gain to date.
COMMODORE CAPITAL LP ELVN ($21.95) Holding Chart
COMMODORE CAPITAL LP ELVN ($21.95) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
